Bruce Patterson MD had made a lot of news with his assertion that very high levels of a chemokine called CCL5/RANTES were directing immune cells to go on the attack in long COVID. Patterson’s first study suggested that a weak adaptive immune response to the virus was causing the immune … Continue reading Good Drug, Bad Company? Leronlimab, long COVID, and Bruce Patterson’s Attempt to Takeover CytoDyn